{"id":27730,"date":"2025-08-12T13:56:21","date_gmt":"2025-08-12T20:56:21","guid":{"rendered":"https:\/\/ameripharmaspecialty.com\/?p=27730"},"modified":"2026-03-20T15:24:25","modified_gmt":"2026-03-20T22:24:25","slug":"ivig-for-opsoclonus-myoclonus-syndrome-oms","status":"publish","type":"post","link":"https:\/\/ameripharmaspecialty.com\/es\/ivig\/ivig-for-opsoclonus-myoclonus-syndrome-oms\/","title":{"rendered":"IgIV para el s\u00edndrome de opsoclono-mioclono (OMS)"},"content":{"rendered":"<p>Si su hijo de repente comienza a tener movimientos oculares r\u00e1pidos e inusuales o comienza a mostrar movimientos musculares espasm\u00f3dicos e incontrolables, estos podr\u00edan ser signos de una afecci\u00f3n llamada s\u00edndrome de opsoclono-mioclono (OMS).&nbsp;<\/p>\n\n\n\n<div  id=\"call-to-action-4dfc65b4e72481154f6da64bbccc5fb7\" style=\"\" class=\"ct_call_to_action\">\n\t<div class=\"container\">\n\t\t<div class=\"block-wrap cta\">\n\t\t\t<div class=\"block-column\">\n\t\t\t\t<div class=\"cta_headings\">\n\t\t\t\t\t\t\t\t\t\t\t<h4 class=\"cta__heading\">\n\t\t\t\t\t\t\tObtenga asistencia para el copago de IgIV\t\t\t\t\t\t<\/h4>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t<span class=\"cta_btn\">\n\t\t\t\t\t\t<a href=\"tel:8777780318\">(877) 778-0318<\/a>\n\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t<\/div>\n\n\t\t<\/div>\n\t<\/div>\n<\/div>\n\n\n\n<p>El OMS es un trastorno neurol\u00f3gico que afecta principalmente a ni\u00f1os peque\u00f1os, aunque en ocasiones tambi\u00e9n puede afectar a adultos. El OMS puede ser una afecci\u00f3n dif\u00edcil de controlar tanto para los pacientes como para sus familias. Sin embargo, puede tratarse si se detecta a tiempo.&nbsp;<\/p>\n\n\n\n<p><a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC5783315\/#S23\">Investigaci\u00f3n<\/a> muestra que agregar <a href=\"https:\/\/ameripharmaspecialty.com\/es\/ivig\/ivig\/\">IgIV<\/a> El tratamiento temprano y est\u00e1ndar para el OMS (es decir, corticosteroides) puede duplicar la tasa de respuesta y mejorar la recuperaci\u00f3n neurol\u00f3gica en ni\u00f1os con diagn\u00f3stico de OMS. Contin\u00fae leyendo para saber qu\u00e9 es el OMS, por qu\u00e9 se produce y c\u00f3mo la IgIV puede ayudarle a usted o a su hijo a recuperar una vida saludable.&nbsp;<\/p>\n\n\n\n<h1 class=\"wp-block-heading\"><strong>\u00bfQu\u00e9 es el s\u00edndrome opsoclono-mioclono (OMS)?<\/strong><\/h1>\n\n\n\n<p>El s\u00edndrome de opsoclono-mioclono es un trastorno neurol\u00f3gico raro y complejo que puede resultar de un ataque del sistema inmunol\u00f3gico al sistema nervioso. <a href=\"https:\/\/rarediseases.info.nih.gov\/diseases\/10009\/opsoclonus-myoclonus-syndrome?utm_medium=email&amp;utm_source=transaction\">Menos de 1.000 personas en EE.UU.<\/a> tener OMS.&nbsp;<\/p>\n\n\n\n<p>Es ligeramente m\u00e1s com\u00fan en ni\u00f1as que en ni\u00f1os. Los s\u00edntomas del OMS suelen comenzar de forma repentina y progresar r\u00e1pidamente. En la mayor\u00eda de los casos, especialmente en ni\u00f1os, los s\u00edntomas comienzan a aparecer entre<strong> <\/strong>6 meses y 3 a\u00f1os de edad.&nbsp;<\/p>\n\n\n\n<p>Los signos y s\u00edntomas comunes del OMS incluyen:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Movimientos oculares r\u00e1pidos e involuntarios en todas direcciones (opsoclono)<strong>)<\/strong><\/li>\n\n\n\n<li>Sacudidas o contracciones musculares r\u00e1pidas e involuntarias (mioclono)<\/li>\n\n\n\n<li>Alteraci\u00f3n del equilibrio (ataxia)<\/li>\n\n\n\n<li>Problemas del habla<\/li>\n\n\n\n<li>Dificultades de conducta y alteraciones del sue\u00f1o<\/li>\n\n\n\n<li>Deterioro cognitivo (especialmente en ni\u00f1os)<\/li>\n<\/ul>\n\n\n\n<p>El OMS tambi\u00e9n se conoce por otros nombres, como s\u00edndrome de ojos bailarines-pies bailarines, s\u00edndrome de Kinsbourne, encefalopat\u00eda opsocl\u00f3nica o s\u00edndrome de opsoclono-mioclono-ataxia (OMA).&nbsp;<\/p>\n\n\n\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_82_2 counter-hierarchy ez-toc-counter ez-toc-custom ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Alternar tabla de contenido\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Palanca<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewbox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewbox=\"0 0 24 24\" version=\"1.2\" baseprofile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/ameripharmaspecialty.com\/es\/ivig\/ivig-for-opsoclonus-myoclonus-syndrome-oms\/#What_Causes_Opsoclonus-Myoclonus_Syndrome_OMS\" >\u00bfQu\u00e9 causa el s\u00edndrome de opsoclono-mioclono (OMS)?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/ameripharmaspecialty.com\/es\/ivig\/ivig-for-opsoclonus-myoclonus-syndrome-oms\/#How_Effective_Is_IVIG_for_Patients_With_Opsoclonus-Myoclonus_Syndrome\" >\u00bfQu\u00e9 tan efectiva es la IgIV para pacientes con s\u00edndrome de opsoclono-mioclono?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/ameripharmaspecialty.com\/es\/ivig\/ivig-for-opsoclonus-myoclonus-syndrome-oms\/#IVIG_for_Opsoclonus-Myoclonus_Syndrome_How_It_Works\" >IgIV para el s\u00edndrome de opsoclono-mioclono: c\u00f3mo funciona<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/ameripharmaspecialty.com\/es\/ivig\/ivig-for-opsoclonus-myoclonus-syndrome-oms\/#Are_There_Any_Side_Effects_of_IVIG\" >\u00bfExisten efectos secundarios de la IgIV?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/ameripharmaspecialty.com\/es\/ivig\/ivig-for-opsoclonus-myoclonus-syndrome-oms\/#When_and_How_Long_Is_IVIG_Therapy_Given_to_OMS_Patients\" >\u00bfCu\u00e1ndo y durante cu\u00e1nto tiempo se administra la terapia con IgIV a los pacientes con OMS?<\/a><\/li><\/ul><\/nav><\/div>\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"What_Causes_Opsoclonus-Myoclonus_Syndrome_OMS\"><\/span><strong>\u00bfQu\u00e9 causa el s\u00edndrome de opsoclono-mioclono (OMS)?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>Aunque todav\u00eda se est\u00e1 estudiando la causa exacta del OMS, los cient\u00edficos creen que es de naturaleza autoinmune, lo que significa que el sistema inmunol\u00f3gico del cuerpo ataca por error a las c\u00e9lulas nerviosas sanas del cerebro.&nbsp;<\/p>\n\n\n<div class=\"wp-block-image\">\n<figure class=\"alignright size-full\"><img loading=\"lazy\" decoding=\"async\" width=\"370\" height=\"226\" src=\"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/08\/b-and-t-cells.jpg\" alt=\"Illustration of B cells and T cells\" class=\"wp-image-27733\" srcset=\"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/08\/b-and-t-cells.jpg 370w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/08\/b-and-t-cells-300x183.jpg 300w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/08\/b-and-t-cells-18x12.jpg 18w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/08\/b-and-t-cells-86x53.jpg 86w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/08\/b-and-t-cells-167x102.jpg 167w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/08\/b-and-t-cells-280x171.jpg 280w\" sizes=\"auto, (max-width: 370px) 100vw, 370px\" \/><\/figure>\n<\/div>\n\n\n<p>En aproximadamente <a href=\"https:\/\/www.mdpi.com\/1648-9144\/56\/8\/412\">40% a 80% de casos pedi\u00e1tricos<\/a>El OMS se desarrolla debido a una enfermedad subyacente, como el neuroblastoma (un c\u00e1ncer que se desarrolla en el tejido nervioso). Cuando el sistema inmunitario inicia una respuesta inmunitaria contra las c\u00e9lulas tumorales, esta tambi\u00e9n afecta al sistema nervioso. La activaci\u00f3n de los linfocitos B y T libera autoanticuerpos y mol\u00e9culas inflamatorias (citocinas) en el cerebro, que da\u00f1an las c\u00e9lulas nerviosas y causan inflamaci\u00f3n en el tronco encef\u00e1lico y el cerebelo (la parte del cerebro que controla el movimiento ocular, el habla y la coordinaci\u00f3n muscular).&nbsp;<\/p>\n\n\n\n<p>Adem\u00e1s, <a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC8625142\/#:~:text=Opsoclonus%2Dmyoclonus%20syndrome%20(OMS),and%20long%2Dterm%20developmental%20sequelae.\">alrededor de 60% de OMS<\/a> Los casos en adultos est\u00e1n relacionados con c\u00e1ncer de pulm\u00f3n de c\u00e9lulas peque\u00f1as, c\u00e1ncer de mama o c\u00e1ncer de ovario, mientras que otros pueden ser resultado de infecciones virales del SNC u otros desencadenantes inmunes desconocidos.<\/p>\n\n\n\n<div  id=\"call-to-action-57e7502a757d2ff1a5e6c148360cc4d6\" style=\"\" class=\"ct_call_to_action\">\n\t<div class=\"container\">\n\t\t<div class=\"block-wrap cta\">\n\t\t\t<div class=\"block-column\">\n\t\t\t\t<div class=\"cta_headings\">\n\t\t\t\t\t\t\t\t\t\t\t<h4 class=\"cta__heading\">\n\t\t\t\t\t\t\tHabla con un especialista\t\t\t\t\t\t<\/h4>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<span class=\"cta__sub__heading\">\n\t\t\t\t\t\t\tAcerca de la asistencia para copagos\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t<span class=\"cta_btn\">\n\t\t\t\t\t\t<a href=\"#form\">Empezar<\/a>\n\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t<\/div>\n\n\t\t<\/div>\n\t<\/div>\n<\/div>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"How_Effective_Is_IVIG_for_Patients_With_Opsoclonus-Myoclonus_Syndrome\"><\/span><strong>\u00bfQu\u00e9 tan efectiva es la IgIV para pacientes con s\u00edndrome de opsoclono-mioclono?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>Los ensayos cl\u00ednicos para determinar la eficacia de la IgIV, ya sea sola o en combinaci\u00f3n con otras terapias, son limitados debido a la rareza de esta enfermedad. Sin embargo, algunos informes de casos han demostrado que la terapia con IgIV es eficaz cuando se usa sola.&nbsp;<\/p>\n\n\n\n<p>Por el contrario, algunos estudios de investigaci\u00f3n muestran que la IgIV tiende a producir mejores resultados cuando se combina con un tratamiento est\u00e1ndar como esteroides (o ACTH) y, a menudo <a href=\"https:\/\/ameripharmaspecialty.com\/es\/cancer\/rituximab-rituxan\/\">rituximab<\/a>.&nbsp;<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>IgIV como monoterapia: evidencia cl\u00ednica<\/strong><\/li>\n<\/ul>\n\n\n\n<p>La monoterapia con IgIV puede considerarse en determinadas situaciones, generalmente cuando los adultos con OMS postinfeccioso no responden a los esteroides y cuando otros inmunosupresores est\u00e1n contraindicados.&nbsp;<\/p>\n\n\n\n<p>Por ejemplo, una <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/27473195\/\">informe de caso<\/a> Se describi\u00f3 el caso de una mujer de 63 a\u00f1os que dio positivo en la prueba del virus del Nilo Occidental y desarroll\u00f3 opsoclono-mioclono progresivo. Recibi\u00f3 tratamiento con IgIV de dos d\u00edas \u00fanicamente \u2014sin esteroides ni otros inmunosupresores\u2014 y logr\u00f3 una remisi\u00f3n neurol\u00f3gica completa en el seguimiento de ocho semanas.<\/p>\n\n\n\n<p>De manera similar, en un <a href=\"https:\/\/www.mdsabstracts.org\/abstract\/sars-cov-2-encephalopathy-presenting-as-opsoclonus-myoclonus-syndrome-successfully-treated-with-iv-immunoglobulins\/?utm_source=chatgpt.com\">caso reportado<\/a> Tras la infecci\u00f3n por SARS-CoV-2, un paciente desarroll\u00f3 un s\u00edndrome de opsoclono-mioclono, caracterizado por psicosis, movimientos oculares ca\u00f3ticos y mioclon\u00edas multifocales. El paciente recibi\u00f3 tratamiento con inmunoglobulina intravenosa (IGIV) con \u00e9xito.<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>IgIV en combinaci\u00f3n con terapias est\u00e1ndar: evidencia cl\u00ednica<\/strong><\/li>\n<\/ul>\n\n\n\n<p>En la mayor\u00eda de los casos de OMS pedi\u00e1tricos y muchos casos paraneopl\u00e1sicos en adultos, la IgIV se utiliza como parte de un r\u00e9gimen multimodal para prevenir reca\u00eddas y mejorar los resultados. A 2025 <a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC11806606\/?utm_source=chatgpt.com#Abs1\">estudio transversal<\/a> Publicado en la Revista Italiana de Pediatr\u00eda demostr\u00f3 que la IgIV combinada con dexametasona y rituximab redujo las reca\u00eddas y las secuelas neurol\u00f3gicas permanentes en ni\u00f1os con OMS.&nbsp;<\/p>\n\n\n\n<p>De la misma manera, una <a href=\"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1111\/dmcn.13349?utm_source=chatgpt.com\">revisi\u00f3n sistem\u00e1tica pedi\u00e1trica<\/a> Se demostr\u00f3 que los pacientes con OMS tratados con IgIV, corticosteroides y rituximab\/<a href=\"https:\/\/ameripharmaspecialty.com\/es\/discontinued\/cyclophosphamide\/\">ciclofosfamida<\/a> Tuvieron resultados significativamente mejores en cuanto a motricidad, lenguaje y coeficiente intelectual, as\u00ed como tasas de reca\u00edda m\u00e1s bajas, en comparaci\u00f3n con los tratados solo con corticosteroides\/ACTH.\u00a0<\/p>\n\n\n\n<p>En resumen, la IgIV sola puede ser eficaz, especialmente en adultos con OMS postinfeccioso, pero cuando se combina con esteroides, ACTH o rituximab, da los mejores resultados en ni\u00f1os.<strong> <\/strong>Un enfoque m\u00faltiple ataca la respuesta autoinmune desde diferentes \u00e1ngulos.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"IVIG_for_Opsoclonus-Myoclonus_Syndrome_How_It_Works\"><\/span>IgIV para el s\u00edndrome de opsoclono-mioclono: c\u00f3mo funciona<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>El mecanismo exacto de acci\u00f3n de la IgIV en pacientes con OMS no est\u00e1 claro. Sin embargo, las investigaciones demuestran que la IgIV inhibe la respuesta inmunitaria y reduce la neuroinflamaci\u00f3n de las siguientes maneras:&nbsp;<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Bloquea los autoanticuerpos da\u00f1inos<\/strong><\/li>\n<\/ul>\n\n\n\n<p>La IgIV contiene anticuerpos saludables que se unen y neutralizan los autoanticuerpos da\u00f1inos que atacan el sistema nervioso en el OMS.<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Modula la actividad de las c\u00e9lulas inmunes<\/strong><\/li>\n<\/ul>\n\n\n\n<p>La IgIV afecta a las c\u00e9lulas inmunes, principalmente a las c\u00e9lulas B (que producen autoanticuerpos) y a las c\u00e9lulas T. <a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC5783315\/#S5\">reduce su hiperactividad<\/a>, lo que provoca una disminuci\u00f3n en la producci\u00f3n de autoanticuerpos y citocinas. Esto ayuda a restablecer el equilibrio del sistema inmunitario.<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Regula las citocinas y reduce la neuroinflamaci\u00f3n.<\/strong><\/li>\n<\/ul>\n\n\n\n<p>En el OMS, el sistema nervioso central muestra evidencia de activaci\u00f3n inmunitaria, incluyendo niveles elevados de citocinas inflamatorias (mol\u00e9culas producidas por c\u00e9lulas B, c\u00e9lulas T y otras c\u00e9lulas inmunitarias activadas). La IgIV ayuda <a href=\"https:\/\/www.sciencedirect.com\/science\/article\/abs\/pii\/S0887899417302102\">reducir la neuroinflamaci\u00f3n<\/a> al disminuir la producci\u00f3n de estas citocinas proinflamatorias.&nbsp;<\/p>\n\n\n\n<p>Al reducir la inflamaci\u00f3n y detener el ataque inmunol\u00f3gico al cerebro, los ni\u00f1os y adultos con OMS experimentan:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Movimiento ocular mejorado&nbsp;<\/li>\n\n\n\n<li>Disminuci\u00f3n de las sacudidas musculares<\/li>\n\n\n\n<li>Recuperaci\u00f3n del equilibrio y la coordinaci\u00f3n<\/li>\n\n\n\n<li>Recuperaci\u00f3n del habla y de las habilidades cognitivas<\/li>\n\n\n\n<li>Riesgo reducido de reca\u00edda, especialmente cuando se inicia la IgIV de forma temprana<\/li>\n<\/ul>\n\n\n\n<div  id=\"call-to-action-6240643088ab819381edf2862657cc27\" style=\"\" class=\"ct_call_to_action\">\n\t<div class=\"container\">\n\t\t<div class=\"block-wrap cta\">\n\t\t\t<div class=\"block-column\">\n\t\t\t\t<div class=\"cta_headings\">\n\t\t\t\t\t\t\t\t\t\t\t<h4 class=\"cta__heading\">\n\t\t\t\t\t\t\tObtenga asistencia financiera\t\t\t\t\t\t<\/h4>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t<span class=\"cta_btn\">\n\t\t\t\t\t\t<a href=\"tel:8777780318\">(877) 778-0318<\/a>\n\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t<\/div>\n\n\t\t<\/div>\n\t<\/div>\n<\/div>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Are_There_Any_Side_Effects_of_IVIG\"><\/span><strong>\u00bfExisten efectos secundarios de la IgIV?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>S\u00ed, la IgIV puede causar algunas <a href=\"https:\/\/ameripharmaspecialty.com\/es\/ivig\/understanding-the-common-side-effects-of-ivig-treatment\/\">efectos secundarios<\/a>Aunque muchos son leves y temporales, los pacientes pueden experimentar efectos secundarios como n\u00e1useas, dolor de cabeza, escalofr\u00edos o fiebre durante o despu\u00e9s de la infusi\u00f3n de IgIV. Sin embargo, con un seguimiento y protocolos de infusi\u00f3n adecuados, estos efectos secundarios son controlables.&nbsp;<\/p>\n\n\n\n<p>En casos raros, <a href=\"https:\/\/ameripharmaspecialty.com\/es\/other-health-conditions\/ivig-and-meningitis-whats-the-link\/\">meningitis as\u00e9ptica<\/a>Tambi\u00e9n pueden producirse trombosis, problemas renales (especialmente en aquellos con enfermedad renal preexistente) o reacciones al\u00e9rgicas o anafil\u00e1cticas, que requieren un control cuidadoso durante el proceso de IgIV.&nbsp;<\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"When_and_How_Long_Is_IVIG_Therapy_Given_to_OMS_Patients\"><\/span><strong>\u00bfCu\u00e1ndo y durante cu\u00e1nto tiempo se administra la terapia con IgIV a los pacientes con OMS?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>El tratamiento con IgIV suele comenzar poco despu\u00e9s del diagn\u00f3stico para ayudar a calmar el sistema inmunitario y aliviar s\u00edntomas como movimientos oculares r\u00e1pidos y espasmos musculares. Se suele usar junto con esteroides u otros medicamentos.<\/p>\n\n\n\n<p>Los ni\u00f1os y adultos con OMS pueden recibir una <a href=\"https:\/\/www.criteria.blood.gov.au\/MedicalCondition\/View\/2583\">Dosis inicial de 1 \u2013 2 g\/kg administrada en dos a cinco dosis divididas<\/a>, seguida de una dosis de mantenimiento de 0,4 \u2013 1 g\/kg administrada cada 4 a 6 semanas para mantener los s\u00edntomas bajo control.&nbsp;<\/p>\n\n\n\n<p>El tratamiento puede durar desde varios meses hasta un par de a\u00f1os, dependiendo de la respuesta del paciente y de si se producen reca\u00eddas.<\/p>\n\n\n\n<p>Consulte con su profesional de la salud si est\u00e1 considerando la IgIV para el s\u00edndrome de opsoclono-mioclono como parte de su plan de tratamiento para el s\u00edndrome de opsoclono-mioclono. Este profesional puede ayudarle a comprender qu\u00e9 esperar seg\u00fan la gravedad de sus s\u00edntomas y su estado general de salud.<\/p>\n\n\n\n<p><\/p>","protected":false},"excerpt":{"rendered":"<p>Si su hijo comienza repentinamente a tener movimientos oculares inusuales y r\u00e1pidos o a mostrar movimientos musculares espasm\u00f3dicos e incontrolables, estos podr\u00edan ser signos de una afecci\u00f3n llamada s\u00edndrome de opsoclono-mioclono (OMS). El OMS es un trastorno neurol\u00f3gico que afecta principalmente a ni\u00f1os peque\u00f1os, pero a veces tambi\u00e9n puede afectar a adultos.<\/p>","protected":false},"author":13,"featured_media":27731,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":true,"om_disable_all_campaigns":false,"_uag_custom_page_level_css":"","footnotes":""},"categories":[7],"tags":[17],"class_list":["post-27730","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-ivig","tag-dr-saba-rassouli"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>IVIG for Opsoclonus-Myoclonus Syndrome (OMS) - AmeriPharma\u00ae Specialty Care<\/title>\n<meta name=\"description\" content=\"Learn how early IVIG for opsoclonus-myoclonus syndrome can improve recovery, reduce relapses, and support better outcomes in children.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ameripharmaspecialty.com\/es\/ivig\/ivig-for-opsoclonus-myoclonus-syndrome-oms\/\" \/>\n<meta property=\"og:locale\" content=\"es_MX\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"IVIG for Opsoclonus-Myoclonus Syndrome (OMS) - AmeriPharma\u00ae Specialty Care\" \/>\n<meta property=\"og:description\" content=\"Learn how early IVIG for opsoclonus-myoclonus syndrome can improve recovery, reduce relapses, and support better outcomes in children.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ameripharmaspecialty.com\/es\/ivig\/ivig-for-opsoclonus-myoclonus-syndrome-oms\/\" \/>\n<meta property=\"og:site_name\" content=\"AmeriPharma\u00ae Specialty Care\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/ameripharma\/\" \/>\n<meta property=\"article:published_time\" content=\"2025-08-12T20:56:21+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-03-20T22:24:25+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/08\/doctor-girl.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1280\" \/>\n\t<meta property=\"og:image:height\" content=\"853\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Dr. Saba Rassouli, PharmD\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Dr. Saba Rassouli, PharmD\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"6 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/ivig\\\/ivig-for-opsoclonus-myoclonus-syndrome-oms\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/ivig\\\/ivig-for-opsoclonus-myoclonus-syndrome-oms\\\/\"},\"author\":{\"name\":\"Dr. Saba Rassouli, PharmD\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#\\\/schema\\\/person\\\/f70b3467e035aab4ae14bdadd64c5c01\"},\"headline\":\"IVIG for Opsoclonus-Myoclonus Syndrome (OMS)\",\"datePublished\":\"2025-08-12T20:56:21+00:00\",\"dateModified\":\"2026-03-20T22:24:25+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/ivig\\\/ivig-for-opsoclonus-myoclonus-syndrome-oms\\\/\"},\"wordCount\":1151,\"publisher\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/ivig\\\/ivig-for-opsoclonus-myoclonus-syndrome-oms\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2025\\\/08\\\/doctor-girl.jpg\",\"keywords\":[\"Dr. Saba Rassouli\"],\"articleSection\":[\"IVIG\"],\"inLanguage\":\"es\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/ivig\\\/ivig-for-opsoclonus-myoclonus-syndrome-oms\\\/\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/ivig\\\/ivig-for-opsoclonus-myoclonus-syndrome-oms\\\/\",\"name\":\"IVIG for Opsoclonus-Myoclonus Syndrome (OMS) - AmeriPharma\u00ae Specialty Care\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/ivig\\\/ivig-for-opsoclonus-myoclonus-syndrome-oms\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/ivig\\\/ivig-for-opsoclonus-myoclonus-syndrome-oms\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2025\\\/08\\\/doctor-girl.jpg\",\"datePublished\":\"2025-08-12T20:56:21+00:00\",\"dateModified\":\"2026-03-20T22:24:25+00:00\",\"description\":\"Learn how early IVIG for opsoclonus-myoclonus syndrome can improve recovery, reduce relapses, and support better outcomes in children.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/ivig\\\/ivig-for-opsoclonus-myoclonus-syndrome-oms\\\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/ivig\\\/ivig-for-opsoclonus-myoclonus-syndrome-oms\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/ivig\\\/ivig-for-opsoclonus-myoclonus-syndrome-oms\\\/#primaryimage\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2025\\\/08\\\/doctor-girl.jpg\",\"contentUrl\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2025\\\/08\\\/doctor-girl.jpg\",\"width\":1280,\"height\":853,\"caption\":\"Doctor talking to a girl about IVIG for Opsoclonus-Myoclonus Syndrome (OMS)\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/ivig\\\/ivig-for-opsoclonus-myoclonus-syndrome-oms\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"IVIG for Opsoclonus-Myoclonus Syndrome (OMS)\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#website\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/\",\"name\":\"AmeriPharma\u00ae Specialty Care\",\"description\":\"Specialty Care by AmeriPharma\",\"publisher\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#organization\",\"name\":\"Ameripharma Specialty Care\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2024\\\/07\\\/specialty-care-logo-large-square.png\",\"contentUrl\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2024\\\/07\\\/specialty-care-logo-large-square.png\",\"width\":400,\"height\":400,\"caption\":\"Ameripharma Specialty Care\"},\"image\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/ameripharma\\\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#\\\/schema\\\/person\\\/f70b3467e035aab4ae14bdadd64c5c01\",\"name\":\"Dr. Saba Rassouli, PharmD\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a5087340dca0d3046e3ff88f5dfa11d515d21ea9e06e6aec23e56d7fddfee7ce?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a5087340dca0d3046e3ff88f5dfa11d515d21ea9e06e6aec23e56d7fddfee7ce?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a5087340dca0d3046e3ff88f5dfa11d515d21ea9e06e6aec23e56d7fddfee7ce?s=96&d=mm&r=g\",\"caption\":\"Dr. Saba Rassouli, PharmD\"},\"description\":\"Dr. Saba Rassouli, PharmD was born and raised in Iran. She received her pharmacy degree from Marshall B. Ketchum University in 2022, where she graduated cum laude. The most rewarding part of her job is having the opportunity to care for each patient as if they were family and hearing about how happy and satisfied they are with the services provided by AmeriPharma. In her free time, she likes to go on walks, read books, and try different restaurants and foods.\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/author\\\/saba-rassouli\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"IgIV para el s\u00edndrome de opsoclono-mioclono (OMS) - AmeriPharma\u00ae Atenci\u00f3n especializada","description":"Aprenda c\u00f3mo la IgIV temprana para el s\u00edndrome de opsoclono-mioclono puede mejorar la recuperaci\u00f3n, reducir las reca\u00eddas y favorecer mejores resultados en los ni\u00f1os.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ameripharmaspecialty.com\/es\/ivig\/ivig-for-opsoclonus-myoclonus-syndrome-oms\/","og_locale":"es_MX","og_type":"article","og_title":"IVIG for Opsoclonus-Myoclonus Syndrome (OMS) - AmeriPharma\u00ae Specialty Care","og_description":"Learn how early IVIG for opsoclonus-myoclonus syndrome can improve recovery, reduce relapses, and support better outcomes in children.","og_url":"https:\/\/ameripharmaspecialty.com\/es\/ivig\/ivig-for-opsoclonus-myoclonus-syndrome-oms\/","og_site_name":"AmeriPharma\u00ae Specialty Care","article_publisher":"https:\/\/www.facebook.com\/ameripharma\/","article_published_time":"2025-08-12T20:56:21+00:00","article_modified_time":"2026-03-20T22:24:25+00:00","og_image":[{"width":1280,"height":853,"url":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/08\/doctor-girl.jpg","type":"image\/jpeg"}],"author":"Dr. Saba Rassouli, PharmD","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Dr. Saba Rassouli, PharmD","Est. reading time":"6 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/ameripharmaspecialty.com\/es\/ivig\/ivig-for-opsoclonus-myoclonus-syndrome-oms\/#article","isPartOf":{"@id":"https:\/\/ameripharmaspecialty.com\/es\/ivig\/ivig-for-opsoclonus-myoclonus-syndrome-oms\/"},"author":{"name":"Dr. Saba Rassouli, PharmD","@id":"https:\/\/ameripharmaspecialty.com\/#\/schema\/person\/f70b3467e035aab4ae14bdadd64c5c01"},"headline":"IVIG for Opsoclonus-Myoclonus Syndrome (OMS)","datePublished":"2025-08-12T20:56:21+00:00","dateModified":"2026-03-20T22:24:25+00:00","mainEntityOfPage":{"@id":"https:\/\/ameripharmaspecialty.com\/es\/ivig\/ivig-for-opsoclonus-myoclonus-syndrome-oms\/"},"wordCount":1151,"publisher":{"@id":"https:\/\/ameripharmaspecialty.com\/#organization"},"image":{"@id":"https:\/\/ameripharmaspecialty.com\/es\/ivig\/ivig-for-opsoclonus-myoclonus-syndrome-oms\/#primaryimage"},"thumbnailUrl":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/08\/doctor-girl.jpg","keywords":["Dr. Saba Rassouli"],"articleSection":["IVIG"],"inLanguage":"es"},{"@type":"WebPage","@id":"https:\/\/ameripharmaspecialty.com\/es\/ivig\/ivig-for-opsoclonus-myoclonus-syndrome-oms\/","url":"https:\/\/ameripharmaspecialty.com\/es\/ivig\/ivig-for-opsoclonus-myoclonus-syndrome-oms\/","name":"IgIV para el s\u00edndrome de opsoclono-mioclono (OMS) - AmeriPharma\u00ae Atenci\u00f3n especializada","isPartOf":{"@id":"https:\/\/ameripharmaspecialty.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/ameripharmaspecialty.com\/es\/ivig\/ivig-for-opsoclonus-myoclonus-syndrome-oms\/#primaryimage"},"image":{"@id":"https:\/\/ameripharmaspecialty.com\/es\/ivig\/ivig-for-opsoclonus-myoclonus-syndrome-oms\/#primaryimage"},"thumbnailUrl":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/08\/doctor-girl.jpg","datePublished":"2025-08-12T20:56:21+00:00","dateModified":"2026-03-20T22:24:25+00:00","description":"Aprenda c\u00f3mo la IgIV temprana para el s\u00edndrome de opsoclono-mioclono puede mejorar la recuperaci\u00f3n, reducir las reca\u00eddas y favorecer mejores resultados en los ni\u00f1os.","breadcrumb":{"@id":"https:\/\/ameripharmaspecialty.com\/es\/ivig\/ivig-for-opsoclonus-myoclonus-syndrome-oms\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ameripharmaspecialty.com\/es\/ivig\/ivig-for-opsoclonus-myoclonus-syndrome-oms\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/ameripharmaspecialty.com\/es\/ivig\/ivig-for-opsoclonus-myoclonus-syndrome-oms\/#primaryimage","url":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/08\/doctor-girl.jpg","contentUrl":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/08\/doctor-girl.jpg","width":1280,"height":853,"caption":"Doctor talking to a girl about IVIG for Opsoclonus-Myoclonus Syndrome (OMS)"},{"@type":"BreadcrumbList","@id":"https:\/\/ameripharmaspecialty.com\/es\/ivig\/ivig-for-opsoclonus-myoclonus-syndrome-oms\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/ameripharmaspecialty.com\/es\/"},{"@type":"ListItem","position":2,"name":"IVIG for Opsoclonus-Myoclonus Syndrome (OMS)"}]},{"@type":"WebSite","@id":"https:\/\/ameripharmaspecialty.com\/#website","url":"https:\/\/ameripharmaspecialty.com\/","name":"Cuidado especializado AmeriPharma\u00ae","description":"Atenci\u00f3n especializada por AmeriPharma","publisher":{"@id":"https:\/\/ameripharmaspecialty.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/ameripharmaspecialty.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/ameripharmaspecialty.com\/#organization","name":"Atenci\u00f3n especializada de Ameripharma","url":"https:\/\/ameripharmaspecialty.com\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/ameripharmaspecialty.com\/#\/schema\/logo\/image\/","url":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/07\/specialty-care-logo-large-square.png","contentUrl":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/07\/specialty-care-logo-large-square.png","width":400,"height":400,"caption":"Ameripharma Specialty Care"},"image":{"@id":"https:\/\/ameripharmaspecialty.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/ameripharma\/"]},{"@type":"Person","@id":"https:\/\/ameripharmaspecialty.com\/#\/schema\/person\/f70b3467e035aab4ae14bdadd64c5c01","name":"Dra. Saba Rassouli, Farmac\u00e9utica","image":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/secure.gravatar.com\/avatar\/a5087340dca0d3046e3ff88f5dfa11d515d21ea9e06e6aec23e56d7fddfee7ce?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a5087340dca0d3046e3ff88f5dfa11d515d21ea9e06e6aec23e56d7fddfee7ce?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a5087340dca0d3046e3ff88f5dfa11d515d21ea9e06e6aec23e56d7fddfee7ce?s=96&d=mm&r=g","caption":"Dr. Saba Rassouli, PharmD"},"description":"La Dra. Saba Rassouli, doctora en farmacia, naci\u00f3 y creci\u00f3 en Ir\u00e1n. Obtuvo su t\u00edtulo en farmacia en la Universidad Marshall B. Ketchum en 2022, donde se gradu\u00f3 con honores. Lo m\u00e1s gratificante de su trabajo es tener la oportunidad de atender a cada paciente como si fuera de su familia y escuchar lo contentos y satisfechos que est\u00e1n con los servicios de AmeriPharma. En su tiempo libre, le gusta pasear, leer y probar diferentes restaurantes y comidas.","url":"https:\/\/ameripharmaspecialty.com\/es\/author\/saba-rassouli\/"}]}},"uagb_featured_image_src":{"full":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/08\/doctor-girl.jpg",1280,853,false],"thumbnail":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/08\/doctor-girl-150x150.jpg",150,150,true],"medium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/08\/doctor-girl-300x200.jpg",300,200,true],"medium_large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/08\/doctor-girl-768x512.jpg",768,512,true],"large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/08\/doctor-girl-1024x682.jpg",1024,682,true],"1536x1536":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/08\/doctor-girl.jpg",1280,853,false],"2048x2048":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/08\/doctor-girl.jpg",1280,853,false],"trp-custom-language-flag":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/08\/doctor-girl-18x12.jpg",18,12,true],"block-image-html-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/08\/doctor-girl-600x400.jpg",600,400,true],"ct-gallery":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/08\/doctor-girl-330x220.jpg",330,220,true],"ct-section-header":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/08\/doctor-girl-1146x380.jpg",1146,380,true],"ct-thumb":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/08\/doctor-girl-86x57.jpg",86,57,true],"ct-thumb-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/08\/doctor-girl-167x111.jpg",167,111,true],"ct-small":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/08\/doctor-girl-280x187.jpg",280,187,true],"ct-medium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/08\/doctor-girl-370x247.jpg",370,247,true],"ct-xmedium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/08\/doctor-girl-960x640.jpg",960,640,true],"ct-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/08\/doctor-girl.jpg",1280,853,false]},"uagb_author_info":{"display_name":"Dr. Saba Rassouli, PharmD","author_link":"https:\/\/ameripharmaspecialty.com\/es\/author\/saba-rassouli\/"},"uagb_comment_info":0,"uagb_excerpt":"If your child suddenly begins having unusual, rapid eye movements or starts showing jerky, uncontrollable muscle movements, these could be signs of a condition called Opsoclonus-Myoclonus Syndrome (OMS).\u00a0OMS is a neurological disorder that mostly affects young children, but sometimes adults can also be affected.","rttpg_featured_image_url":{"full":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/08\/doctor-girl.jpg",1280,853,false],"landscape":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/08\/doctor-girl.jpg",1280,853,false],"portraits":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/08\/doctor-girl.jpg",1280,853,false],"thumbnail":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/08\/doctor-girl-150x150.jpg",150,150,true],"medium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/08\/doctor-girl-300x200.jpg",300,200,true],"large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/08\/doctor-girl-1024x682.jpg",1024,682,true],"1536x1536":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/08\/doctor-girl.jpg",1280,853,false],"2048x2048":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/08\/doctor-girl.jpg",1280,853,false],"trp-custom-language-flag":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/08\/doctor-girl-18x12.jpg",18,12,true],"block-image-html-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/08\/doctor-girl-600x400.jpg",600,400,true],"ct-gallery":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/08\/doctor-girl-330x220.jpg",330,220,true],"ct-section-header":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/08\/doctor-girl-1146x380.jpg",1146,380,true],"ct-thumb":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/08\/doctor-girl-86x57.jpg",86,57,true],"ct-thumb-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/08\/doctor-girl-167x111.jpg",167,111,true],"ct-small":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/08\/doctor-girl-280x187.jpg",280,187,true],"ct-medium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/08\/doctor-girl-370x247.jpg",370,247,true],"ct-xmedium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/08\/doctor-girl-960x640.jpg",960,640,true],"ct-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/08\/doctor-girl.jpg",1280,853,false]},"rttpg_author":{"display_name":"Dr. Saba Rassouli, PharmD","author_link":"https:\/\/ameripharmaspecialty.com\/es\/author\/saba-rassouli\/"},"rttpg_comment":0,"rttpg_category":"<a href=\"https:\/\/ameripharmaspecialty.com\/es\/category\/ivig\/\" rel=\"category tag\">IVIG<\/a>","rttpg_excerpt":"If your child suddenly begins having unusual, rapid eye movements or starts showing jerky, uncontrollable muscle movements, these could be signs of a condition called Opsoclonus-Myoclonus Syndrome (OMS).\u00a0OMS is a neurological disorder that mostly affects young children, but sometimes adults can also be affected.","_links":{"self":[{"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/posts\/27730","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/users\/13"}],"replies":[{"embeddable":true,"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/comments?post=27730"}],"version-history":[{"count":0,"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/posts\/27730\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/media\/27731"}],"wp:attachment":[{"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/media?parent=27730"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/categories?post=27730"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/tags?post=27730"}],"curies":[{"name":"gracias","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}